W
WAVEMAN · COMPANY
MTEX · Mannatech Inc
> Ask across nine datasets ⌘K
LIVE
TEAM-2.62% 13F +440META+1.00% 13F +2,694RCG+0.35% CLUSTERUTHR-0.54% 13F +425CRWV+5.68% 13F +694CRM-1.97% 13F +1,019CVNA+1.58% 13F +795TPL-1.11% 13F +444NET-1.96% 13F +711MSTR-1.39% 13F +527DELL+1.50% 13F +1,204CRWD-0.87% 13F +1,383ANET+1.22% 13F +1,324COIN-4.18% 13F +475TEAM-2.62% 13F +440META+1.00% 13F +2,694RCG+0.35% CLUSTERUTHR-0.54% 13F +425CRWV+5.68% 13F +694CRM-1.97% 13F +1,019CVNA+1.58% 13F +795TPL-1.11% 13F +444NET-1.96% 13F +711MSTR-1.39% 13F +527DELL+1.50% 13F +1,204CRWD-0.87% 13F +1,383ANET+1.22% 13F +1,324COIN-4.18% 13F +475
← ALL COMPANIES

MTEX

MANNATECH INC
PHARMA & BIOTECH · MEDICINAL CHEMICALS & BOTANICAL PRODUCTS · CIK 0001056358
ACTIVIST 13D☆ WATCH
INSIDER NET · 180D
$62.2K
open-market buys minus sells, Form 4 codes P and S
INSIDER BUYERS · 180D
2
CONGRESS BUYERS · 1Y
0
FUNDS ADDED · QTR
5
13F, latest reported quarter
REVENUE GROWTH
-8.3%
XBRL, annual
NET MARGIN
-14.1%
SEVEN FACTS, RANKED AGAINST THE SECTOR · RANK IS NOT A FORECAST
INSIDERS
net +$62.2K over 180 days
more than 74% of Pharma & Biotech
CONGRESS
no member of Congress has reported trading it
FUNDS
5 funds added or opened last quarter
below 96% of Pharma & Biotech
REVENUE
-8.3% year over year
below 69% of Pharma & Biotech
MARGIN
-14.1% net margin
more than 53% of Pharma & Biotech
BUYBACKS
no share repurchases reported
SHORT
0.8% of shares outstanding short · 1.4 days to cover · settled 2026-07-31
below 74% of Pharma & Biotech
THE SITUATION · EVERY LINE IS ONE RULE OVER ONE DATASET
TOTH ROBERT disclosed a 5%+ stake (5.1%) in the last six months.
The year, with the filings on it
Total return indexed to 100 over the last 12 months · every marker is a federal filing, placed at its date — hover any marker for the detail
TOTAL 12M RETURN +4.7%
+4.7%12M
-54%-30%-6%+18%2025-092025-102025-122026-032026-052026-072026-09 2026-05-19 · Robbins Kevin Andrew bought $29.6K2026-05-19 · JOBE LARRY A bought $21.0K2026-05-20 · JOBE LARRY A bought $11.5K2026-04-24 · TOTH ROBERT filed a 5%+ stake (5.1%)
INSIDER BUY13D/G STAKE
INDEXED RETURN, DIVIDEND-ADJUSTED — NOT A PRICE CHART · LARGE TRADES DRAWN FIRST WHEN A NAME FILES HEAVILY
Live price
Daily candles from TradingView, on their licence — no filings are marked on this one
WHY THIS NAME IS ON THE DESK
An activist crossed the 5% line with declared intent.
The record shows a net $62.2K bought by insiders over 180 days, 5 funds added last quarter. Every figure is a federal filing, dated the day it became public.
Same sector, ranked by filing activity
Sector from the SEC's own SIC classification
Insider transactions
Form 4 purchases and sales (codes P and S) — grants, option exercises and preferred conversions excluded

Over the last 180 days, MANNATECH INC insiders bought a net $62.2K of stock across 18 Form 4 purchases and sales, with 2 insider(s) buying. Source: SEC Form 4 filings, as of 2026-09-06.

INSIDER
FILED
SHARES
VALUE
JOBE LARRY A
Director
BUY
2026-05-20
2,803.0
$11.5K
JOBE LARRY A
Director
BUY
2026-05-19
5,000.0
$21.0K
Robbins Kevin Andrew
Director
BUY
2026-05-19
7,100.0
$29.6K
JOBE LARRY A
Director
SELL
2024-09-09
16,288.0
$126.2K
Rameson Tyler
Director
BUY
2024-09-09
16,288.0
$126.2K
18 TRANSACTIONS ON RECORD

Showing the most recent few. Create a free account to see 13 more transactions on record, the cross-source screener and CSV export. We store only your email address, and there is no password to create.

Institutional holders
13F · holdings as of the latest quarter funds have reported
BlackRock, Inc.
52,163.0 sh
$271.8K
VANGUARD CAPITAL MANAGEMENT LLC
41,528.0 sh
$216.4K
RENAISSANCE TECHNOLOGIES LLC
30,078.0 sh
$156.7K
IFG Advisory, LLC
19,090.0 sh
$99.5K
VANGUARD FIDUCIARY TRUST CO
2,679.0 sh
$14.0K
5%+ owners
13D = intent to influence · 13G = passive
TOTH ROBERT
ACTIVIST 13D · 2026-04-24
5.1%
FORM 144
No planned-sale notices
No insider has notified an intent to sell. This is the panel to watch after a run-up.
Fund concentration
N-PORT · funds ranked by how much of THEMSELVES they put in this stock — the conviction number 13F cannot show
Ultra-Small Company Fund
$140.3K POSITION · AS OF 2026-03-31
0.2%
VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND
$64.7K POSITION · AS OF 2026-03-31
0.0%
Dimensional US Core Equity 1 ETF
$5.3K POSITION · AS OF 2026-04-30
0.0%
Fidelity Extended Market Index Fund
$44.1K POSITION · AS OF 2026-02-28
0.0%
Dimensional U.S. Targeted Value ETF
$11.1K POSITION · AS OF 2026-04-30
0.0%
VANGUARD EXTENDED MARKET INDEX FUND
$44.4K POSITION · AS OF 2026-03-31
0.0%
SEC N-PORT, MONTHLY WITH A ~60-DAY PUBLIC LAG · FUNDS ≥ $10M · % = SHARE OF THE FUND'S OWN BOOK
Executive pay vs shareholder return · Landen Fredrick
DEF 14A pay-versus-performance disclosure · both the headline pay and the SEC's mark-to-market figure, beside the return the company delivered and the return of the peer group it chose itself
FY
CEO TOTAL
ACTUALLY PAID
OTHER NEOs AVG
TSR
PEER TSR
2025
$368.8K
$368.8K
$144.8K
-39%
2024
$641.1K
$641.1K
$90.4K
+66%
2023
$491.0K
$491.0K
$313.1K
-53%
TAGGED BY THE COMPANY UNDER SEC ITEM 402(v) · RETURN IS CUMULATIVE FROM THE START OF THE DISCLOSURE PERIOD · GREEN WHERE THE COMPANY BEAT ITS OWN PEER GROUP
Fundamentals
Annual figures from XBRL filings · pick a past date to see them exactly as the market knew them then — restatements and all
2025-122024-122023-122022-12
REVENUE$108.0M$117.9M$132.0M$137.2M
GROSS PROFIT$81.0M$91.5M$102.9M$104.1M
OPERATING INCOME$-426.0K$1.4M$-964.0K$-405.0K
NET INCOME$-15.2M$2.5M$-2.2M$-4.5M
EPS (DILUTED)-8.001.32-1.20-2.35
OPERATING CASH FLOW$-3.0M$2.3M$-2.4M$-2.6M
CASH$6.2M$11.4M$7.7M$13.8M
LONG-TERM DEBT$2.8M
BUYBACKS$0$176.0K$2.0M
DIVIDENDS PAID$0$748.0K$1.5M
SEC XBRL · FISCAL-YEAR PERIODS · AS KNOWN ON 2026-09-06 · NOBODY ELSE SHOWS FUNDAMENTALS AS OF A PAST DATE
W WAVEMAN

Public filings, honestly analyzed. Official US government sources in one desk — every figure carries the date it was filed, and the methodology is published, backtest included.

SEC FORM 4FORM 13F 13D/GFORM 144XBRL STOCK ACTCONTRACTSFEC CFPBNRC
© 2026 WAVEMAN · SOURCE: SEC EDGAR & OFFICIAL GOVERNMENT DATA · NOT INVESTMENT ADVICE · CHART BY TRADINGVIEW · UPDATED 2026-09-06 ALL SYSTEMS LIVE FOR MACHINES →